Supernus Pharmaceuticals (SUPN) Depreciation and Depletion (2011 - 2015)

Supernus Pharmaceuticals (SUPN) has 5 years of Depreciation and Depletion data on file, last reported at $160000.0 in Q2 2015.

• Depreciation and Depletion for Q2 2015 came in at $160000.0, down 9.09% year-over-year; the trailing twelve-month figure through Jun 2015 was $670000.0 (up 3.88% YoY), and the FY2014 annual result was $699000.0, up 36.52% from the prior year.
• Depreciation and Depletion climbed to $160000.0 in Q2 2015 per SUPN's latest filing, from $156000.0 in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $156.0 million in Q2 2012 and troughed at $105000.0 in Q2 2013.
• A 5-year average of $9.3 million and a median of $164000.0 in 2012 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2012 and 2013: Depreciation and Depletion soared 96794.41% in 2012, then slumped 99.93% in 2013.
• A 5-year view of Depreciation and Depletion shows it stood at $171000.0 in 2011, then retreated by 4.09% to $164000.0 in 2012, then declined by 4.27% to $157000.0 in 2013, then grew by 8.28% to $170000.0 in 2014, then decreased by 5.88% to $160000.0 in 2015.
• Business Quant data shows SUPN's Depreciation and Depletion at $160000.0 in Q2 2015, $156000.0 in Q1 2015, and $170000.0 in Q4 2014.